Dr. Dan Judge and Dr. C. Michael Gibson discuss new findings from a study evaluating the differential stabilization of transthyretin (TTR) with acoramidis and tafamidis. The study found greater TTR stabilization with acoramidis across multiple analyses, including in vitro testing of 51 patient samples representing 17 unique TTR variants.
Sponsored by an independent educational grant from BridgeBio Inc.